Induced Abortions in Women With Rheumatoid Arthritis Receiving Methotrexate
Authors:
Open Access
- 16 April 2013
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 65 (8) , 1365-1369
Abstract
Objective: To determine the rate of induced abortions in women with rheumatoid arthritis (RA) exposed to methotrexate (MTX) compared with women with RA unexposed to this medication.Methods: We performed a nested case–control study using administrative databases from Quebec. All women with RA ages 15–45 years were identified and cases were defined as women having an induced abortion. Each case was matched to ≥1 controls for age, calendar time, and cohort entry. Exposure was defined as having filled ≥1 prescriptions of MTX ≤16 weeks prior to the index date.Results: We identified 112 cases of induced abortions in women with RA and 5,855 RA controls. Exposure to MTX occurred in 10.7% of cases and 21.7% of controls. Women exposed to MTX had a lower rate of induced abortions compared with unexposed women (rate ratio [RR] 0.47 [95% confidence interval (95% CI) 0.25–0.89]). In the multivariate analysis, there was a trend toward an increased rate of induced abortions among women exposed to anti–tumor necrosis factor (anti‐TNF) agents (RR 2.07 [95% CI 0.81–5.27]).Conclusion: Women with RA exposed to MTX have a lower rate of induced abortions than unexposed women. Women with RA exposed to anti‐TNF agents may have an increased rate of induced abortions compared to unexposed women.Keywords
Funding Information
- Canadian Institutes for Health Research Fellowship
- Fonds de Recherche en Santé du Québec Career award
- Fonds de Recherche en Santé du Québec Career award and a Canadian Institutes for Health Research Junior Investigator award
This publication has 10 references indexed in Scilit:
- Effectiveness of Long-Acting Reversible ContraceptionNew England Journal of Medicine, 2012
- Rheumatoid Arthritis Disease Severity Indices in Administrative Databases: A Systematic ReviewThe Journal of Rheumatology, 2011
- Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathiesArthritis Care & Research, 2011
- BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapiesRheumatology, 2010
- Congenital Malformations: Agreement Between Diagnostic Codes in an Administrative Database and Mothers’ ReportsJournal of Obstetrics and Gynaecology Canada, 2010
- Social desirability bias in family planning studies: a neglected problemContraception, 2009
- Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, CanadaArthritis Care & Research, 2009
- Agreement between administrative databases and medical charts for pregnancy‐related variables among asthmatic womenPharmacoepidemiology and Drug Safety, 2008
- Discontinuation of Methotrexate Therapy in Older Patients with Newly Diagnosed Rheumatoid ArthritisDrugs & Aging, 2008
- The effects of methotrexate on pregnancy, fertility and lactationQJM: An International Journal of Medicine, 1999